Corbus Pharmaceuticals Holdings, Inc. (CRBP): Price and Financial Metrics

Corbus Pharmaceuticals Holdings, Inc. (CRBP): $6.74

0.08 (+1.20%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add CRBP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#152 of 362

in industry

CRBP Price/Volume Stats

Current price $6.74 52-week high $13.17
Prev. close $6.66 52-week low $2.11
Day low $6.28 Volume 4,000
Day high $6.74 Avg. volume 173,919
50-day MA $6.71 Dividend yield N/A
200-day MA $6.55 Market Cap 29.82M

CRBP Stock Price Chart Interactive Chart >


Corbus Pharmaceuticals Holdings, Inc. (CRBP) Company Bio


Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. The company is based in Norwood, Massachusetts.


CRBP Latest News Stream


Event/Time News Detail
Loading, please wait...

CRBP Latest Social Stream


Loading social stream, please wait...

View Full CRBP Social Stream

Latest CRBP News From Around the Web

Below are the latest news stories about CORBUS PHARMACEUTICALS HOLDINGS INC that investors may wish to consider to help them evaluate CRBP as an investment opportunity.

Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today provided a corporate update and reported financial results for the second quarter of 2023.

Yahoo | August 8, 2023

Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fireside chat and one-on-one investor meetings at the BTIG Virtual Biotechnology Conference, to be held August 7-8, 2023.

Yahoo | July 31, 2023

26 Biggest Marijuana Companies in the World

This article will discuss the 26 biggest marijuana companies in the world, understand some recent industry trends, and navigate the future of the marijuana industry. If you want to skip our detailed analysis, you can head directly to the 5 Biggest Marijuana Companies in the World. An Analysis of the Cannabis Industry According to a […]

Yahoo | July 26, 2023

Corbus Pharmaceuticals Set to Join Russell Microcap® Index

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that the Company is set to join the Russell Microcap® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens today, as part of the 2023 Russell indexes reconstitution.

Yahoo | June 26, 2023

Corbus Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference, to be held in New York, NY June 7-9, 2023. Management will also be available for one-on-one investor meetings during the conference.

Yahoo | May 31, 2023

Read More 'CRBP' Stories Here

CRBP Price Returns

1-mo -7.67%
3-mo -14.03%
6-mo 5.31%
1-year 36.16%
3-year -87.52%
5-year -97.00%
YTD 103.32%
2022 -82.05%
2021 -50.74%
2020 -77.11%
2019 -6.51%
2018 -17.75%

Continue Researching CRBP

Here are a few links from around the web to help you further your research on Corbus Pharmaceuticals Holdings Inc's stock as an investment opportunity:

Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Price | Nasdaq
Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Quote, History and News - Yahoo Finance
Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!